Showing results (121-130 of 302) with videos related to

Sort By:
Pageof 31
Cancer|November 20, 2023
Safety and efficacy of ibrutinib in combination with rituximab and lenalidomide in previously untreated follicular and marginal zone lymphoma: An open label, phase 2 studyMax J Gordon, Lei Feng, Paolo Strati, et al.
Blood Cancer Discovery|June 24, 2026
A Patient-Derived Xenograft Repository Capturing Clinical and Molecular Heterogeneity of Large B-cell LymphomaHaopeng Yang, Kotaro Arita, Kevin Bowman, et al.
Haematologica|February 8, 2020
Ataxia-telangiectasia mutated interacts with Parkin and induces mitophagy independent of kinase activity. Evidence from mantle cell lymphomaAloke Sarkar, Christine M Stellrecht, Hima V Vangapandu, et al.
Biorxiv : the Preprint Server for Biology|February 6, 2026
A patient derived xenograft repository capturing clinical and molecular heterogeneity of large B-cell lymphomaHaopeng Yang, Kotaro Arita, Kevin Bowman, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 16, 2021
IL-1α Mediates Innate and Acquired Resistance to Immunotherapy in MelanomaShubhra Singh, Zhilan Xiao, Karishma Bavisi, et al.
The American Journal of Surgical Pathology|August 10, 2020
Postchemotherapy Histiocyte-rich Pseudotumor Mimicking Residual Lymphoma: A Report of 11 Cases Correlating Clinicopathologic and Radiologic FindingsHong Fang, Hubert H Chuang, Paolo Strati, et al.
Annals of Hematology|May 17, 2019
Ruxolitinib therapy is associated with improved renal function in patients with primary myelofibrosisPaolo Strati, Maen Abdelrahim, Umut Selamet, et al.
Journal for Immunotherapy of Cancer|December 28, 2020
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of lymphomaSattva S Neelapu, Sherry Adkins, Stephen M Ansell, et al.
Cancer|August 15, 2013
Myelosuppression after frontline fludarabine, cyclophosphamide, and rituximab in patients with chronic lymphocytic leukemia: analysis of persistent and new-onset cytopeniaPaolo Strati, William Wierda, Jan Burger, et al.
Nature Medicine|October 6, 2020
Characteristics of anti-CD19 CAR T cell infusion products associated with efficacy and toxicity in patients with large B cell lymphomasQing Deng, Guangchun Han, Nahum Puebla-Osorio, et al.
Pageof 31